Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate Covid19”

355 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 355 results

Large-scale testing (Phase 3)Study completedNCT05321394
What this trial is testing

Non-inferiority Trial on Treatments in Early COVID-19

Who this might be right for
COVID-19
Azienda Ospedaliera Universitaria Integrata Verona 536
Very early researchStudy completedNCT04516954
What this trial is testing

Convalescent Plasma for COVID-19 Patients

Who this might be right for
COVID 19
Vinmec Research Institute of Stem Cell and Gene Technology 4
Large-scale testing (Phase 3)Ended earlyNCT05205759
What this trial is testing

Non-inferiority Trial on Monoclonal Antibodies in COVID-19

Who this might be right for
COVID-19
Azienda Ospedaliera Universitaria Integrata Verona 319
Testing effectiveness (Phase 2)Ended earlyNCT04880109
What this trial is testing

APX-115 in Hospitalized Patients With Confirmed Mild to Moderate COVID-19.

Who this might be right for
COVID-19
Aptabio Therapeutics, Inc. 16
Testing effectiveness (Phase 2)Study completedNCT04427098
What this trial is testing

Enoxaparin in COVID-19 Moderate to Severe Hospitalized Patients

Who this might be right for
COVID-19
IRCCS Azienda Ospedaliero-Universitaria di Bologna 301
Testing effectiveness (Phase 2)UnknownNCT04595136
What this trial is testing

Study to Evaluate the Efficacy of COVID19-0001-USR in Patients With Mild/or Moderate COVID-19 Infection in Outpatient

Who this might be right for
SARS-CoV-2 Infection
United Medical Specialties 60
Early research (Phase 1)WithdrawnNCT04801056
What this trial is testing

Study of TB006 in Outpatient Patients With Mild to Moderate COVID-19

Who this might be right for
Covid19
TrueBinding, Inc.
Large-scale testing (Phase 3)Ended earlyNCT04332107
What this trial is testing

Azithromycin for COVID-19 Treatment in Outpatients Nationwide

Who this might be right for
COVID-19SARS-CoV-2
Thomas M. Lietman 263
Large-scale testing (Phase 3)UnknownNCT04516811
What this trial is testing

Therapeutic Use of Convalescent Plasma in the Treatment of Patients With Moderate to Severe COVID-19

Who this might be right for
COVID-19SARS-CoV-2 InfectionSevere Acute Respiratory Syndrome Coronavirus 2
South African National Blood Service 600
Testing effectiveness (Phase 2)UnknownNCT06042764
What this trial is testing

SA55 Injection Phase II Study in the Treatment of Mild/Moderate COVID-19 Patients

Who this might be right for
Infection of Upper Respiratory Tract Caused by 2019-nCoV
Sinovac Life Sciences Co., Ltd. 150
Not applicableStudy completedNCT05911022
What this trial is testing

Probiotic and Colchicine in COVID-19

Who this might be right for
COVID-19
Ain Shams University 150
Not applicableStudy completedNCT04664010
What this trial is testing

Efficacy and Safety of High-dose Vitamin C Combined With Chinese Medicine Against Coronavirus Pneumonia (COVID-19)

Who this might be right for
COVID-19
Xi'an International Medical Center Hospital 30
Testing effectiveness (Phase 2)Study completedNCT04330586
What this trial is testing

A Trial of Ciclesonide in Adults With Mild-to-moderate COVID-19

Who this might be right for
COVID-19
Korea University Guro Hospital 68
Not applicableStudy completedNCT04481620
What this trial is testing

Development and Validation of a Prediction Model for the Transition From Mild to Moderate Form of COVID-19, Using Data From Chest CT

Who this might be right for
COVID-19
University Hospital, Bordeaux 1,329
Testing effectiveness (Phase 2)Study completedNCT06676709
What this trial is testing

Effect of IMMUNEPOTENT-CRP on Serum Pro-Inflammatory Cytokines in Mild to Moderate COVID-19

Who this might be right for
COVID-19SARS-CoV2 Infection
Universidad Autonoma de Nuevo Leon 80
Testing effectiveness (Phase 2)Study completedNCT04363736
What this trial is testing

Investigate Intravenous Tocilizumab in Participants With Moderate to Severe COVID-19 Pneumonia

Who this might be right for
COVID-19 Pneumonia
Hoffmann-La Roche 97
Not applicableLooking for participantsNCT04363541
What this trial is testing

Local Thermotherapy for Patients With Mild-to-moderate COVID-19

Who this might be right for
COVID-19Thermotherapy
Instituto Nacional de Perinatologia 274
Testing effectiveness (Phase 2)Ended earlyNCT04415151
What this trial is testing

Tofacitinib for Treatment of Moderate COVID-19

Who this might be right for
COVID-19 Pneumonia
Yale University 24
Very early researchTemporarily pausedNCT04329572
What this trial is testing

Efficacy and Safety of Hydroxychloroquine and Azithromycin for Patients With Moderate to Severe COVID-19

Who this might be right for
COVID-19
Azidus Brasil 400
Large-scale testing (Phase 3)Study completedNCT05249777
What this trial is testing

A Phase III, Randomised, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of TD0069 Capsule for Patients With Mild to Moderate COVID-19

Who this might be right for
COVID-19
Sao Thai Duong Joint Stock Company 573
Load More Results